$AXON Sio Gene Therapies Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sio Gene Therapies Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Sio Gene Therapies Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Sio Gene Therapies Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Adasczik Michael | Principal Accounting Officer | 0 | 0 | May 02 2017 | |||
| Altmeyer Mark | Pres (ASG) & Chief Comm. Ofc. | 2,300 | 29,831 | Mar 16 2018 | |||
| Bazley Mathew C. | General Counsel | 0 | 0 | Apr 17 2019 | |||
| Bickerstaff George | Director | 50,000 | 648,500 | Apr 17 2019 | |||
| Cheruvu Pavan | Chief Executive Officer | 180,426 | 2,340,125 | Apr 19 2021 | |||
| Corcoran Gavin | Chief R&D Officer | 25,792 | 334,522 | Apr 19 2021 | |||
| Cvijic Christine Mikail | Chief Admin Officer and GC | 0 | 0 | May 03 2016 | |||
| Dexxon Holdings Ltd. | 10% Owner | 99,285,714 | 1,287,735,711 | Dec 20 2018 | |||
| FALBERG KATHRYN E | Director | 53,937 | 699,563 | May 16 2017 | |||
| FRIEDHOFF LAWRENCE MD PHD | Chief Development Officer | 0 | 0 | May 02 2017 | |||
| Hung David | Principal Executive Officer | 539,375 | 6,995,694 | Jan 03 2018 | |||
| JEFFS ROGER | Director | 0 | 0 | Apr 17 2019 | |||
| Lo Andrew | 10% Owner | 105,952,381 | 1,374,202,382 | Mar 19 2019 | |||
| Lombardo Ilise | Chief Medical Officer | 0 | 0 | Aug 17 2018 | |||
| Machado Clarence Patrick | 10% Owner | 105,952,381 | 1,374,202,382 | Mar 19 2019 | |||
| McCourt Marion | Principal Operating Officer | 0 | 0 | Apr 11 2017 | |||
| Modig Berndt | Director | 77,914 | 1,010,545 | Apr 19 2021 | |||
| Mohr Stephen Frederick | General Counsel | 0 | 0 | Mar 16 2018 | |||
| Nassif David W. | Chief Financial Officer | 34,004 | 441,032 | Apr 19 2021 | |||
| OLANOFF LAWRENCE S | Director | 0 | 0 | May 02 2017 | |||
| Pande Atul | Director | 33,370 | 432,809 | Apr 19 2021 | |||
| Pisano Gary P. | Director | 0 | 0 | May 02 2017 | |||
| POTTER MYRTLE S | Director | 0 | 0 | Apr 17 2019 | |||
| QVT Associates GP LLC | 10% Owner | 105,952,381 | 1,374,202,382 | Mar 19 2019 | |||
| Ramaswamy Vivek | Principal Executive Officer | 0 | 0 | May 03 2016 | |||
| Roivant Sciences Ltd. | 10% Owner | 18,577,380 | 240,948,619 | Feb 27 2020 | |||
| Romeo Marianne L. | Head,Global Trans & Risk Mgmt | 0 | 0 | May 03 2016 | |||
| Sundaram Senthil Vel | Director | 0 | 0 | Apr 19 2021 | |||
| SVF Investments (UK) Ltd | 10% Owner | 105,952,381 | 1,374,202,382 | Mar 19 2019 | |||
| Torti Frank | Director | 0 | 0 | Apr 19 2021 | |||
| VERNON W ANTHONY | Director | 53,937 | 699,563 | May 16 2017 | |||
| VIKING GLOBAL INVESTORS LP | 10% Owner | 105,952,381 | 1,374,202,382 | Mar 19 2019 | |||
| VIKING GLOBAL PERFORMANCE LLC | 10% Owner | 105,952,381 | 1,374,202,382 | Mar 19 2019 | |||
| Vuori Kristiina MD | Director | 0 | 0 | Apr 19 2021 | |||
| Weinhoff Gregory M | Principal Financial Officer | 0 | 0 | Mar 16 2018 |